[go: up one dir, main page]

Malik et al., 2025 - Google Patents

Receptor for Advanced Glycation End Products in Pulmonary Diseases

Malik et al., 2025

Document ID
11707850706927177770
Author
Malik P
Rani R
Mukherjee T
Publication year
Publication venue
Glycosylation and Glycation in Health and Diseases

External Links

Snippet

The receptor for advanced glycation end products (RAGE) is characterized as a multi-ligand pattern recognition receptor molecule exhibiting physiologically profuse expression in the lung alveolar type 1 (AT-1) epithelial cell's basolateral region. Advanced glycation end …
Continue reading at www.benthamdirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines

Similar Documents

Publication Publication Date Title
Li et al. (Pro) renin receptor is an amplifier of Wnt/β-catenin signaling in kidney injury and fibrosis
Zou et al. Complement factor B is the downstream effector of TLRs and plays an important role in a mouse model of severe sepsis
Horvath et al. Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma
CA2830069C (en) Therapeutic agent for emphysema and copd
Bossé et al. Controversy surrounding the increased expression of TGFβ1 in asthma
Khaket et al. The potential of receptor for advanced glycation end products (RAGE) as a therapeutic target for lung associated diseases
US9441226B2 (en) Methods and compositions for panic disorders
Weng et al. Fibroblast growth factor 21 attenuates salt-sensitive hypertension-induced nephropathy through anti-inflammation and anti-oxidation mechanism
Ding et al. RGD peptides protects against acute lung injury in septic mice through Wisp1-integrin β6 pathway inhibition
Chang et al. Inhibition on CXCL5 reduces aortic matrix metalloproteinase 9 expression and protects against acute aortic dissection
Gatica et al. Expression suppression and activity inhibition of TRPM7 regulate cytokine production and multiple organ dysfunction syndrome during endotoxemia: a new target for sepsis
Werner et al. Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice
CN103687621A (en) Monoclonal Antibodies and Antigens for Diagnosis and Treatment of Lung Diseases and Injuries
Tong et al. Silencing information regulator 1 ameliorates lipopolysaccharide-induced acute lung injury in rats via the upregulation of caveolin-1
Zeng et al. Inhibition of TXNDC5 attenuates lipopolysaccharide-induced septic shock by altering inflammatory responses
Jiang et al. ACE2 deficiency inhibits thoracic aortic dissection by enhancing SIRT3 mediated inhibition of inflammation and VSCMs phenotypic switch
Malik et al. Receptor for Advanced Glycation End Products in Pulmonary Diseases
WO2010121207A9 (en) Methods and compositions related to the interaction of t-cadherin and adiponectin
Li et al. Abnormally decreased renal Klotho is linked to endoplasmic reticulum-associated degradation in mice
US20130071495A1 (en) Inhibitors of glycogen synthase kinase 3 for use in therapeutic methods and screening method relating thereto
US20240044915A1 (en) Use of stromal cell-derived factor 1 (sdf1) as a biomarker for diagnosing and treating severe acute respiratory distress syndrome (ards)
Wu et al. 5-methoxytryptophan protects against toll-like receptor 2-mediated renal tissue inflammation and fibrosis in a murine unilateral ureteral obstruction model
Simó-Servat et al. The ERM complex: a new player involved in diabetes-induced vascular leakage
EP1882937A1 (en) Method for diagnosis of severity and prediction of recurrence in eosinophilic inflammatory disease
Wang et al. Changes in kidney VEGF expression in rats post-cardiopulmonary resuscitation under low-pressure and hypoxia